B7-H3 over expression in prostate cancer promotes tumor cell progression

Journal of Urology

Volumn 186, Issue 3, 2011, Pages 1093-1099

  Yuan, Hexing ^a   Wei, Xuedong ^a   Zhang, Guangbo ^b   Li, Chen ^a   Zhang, Xueguang ^b   Hou, Jianquan ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

cell adhesion; cell migration inhibition; neoplasm invasiveness; prostate; prostatic neoplasms

Indexed keywords

B7 H3 PROTEIN; FIBRONECTIN; PEPTIDES AND PROTEINS; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RNA INTERFERENCE;

AGED; AGED, 80 AND OVER; ANTIGENS, CD; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RECEPTORS, IMMUNOLOGIC;

EID: 80051550965     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.04.103     Document Type: Article

References (30)

1. R.K. Berglund, T.A. Masterson, and K.C. Vora Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance J Urol 180 2008 1964
2. T.J. Roth, Y. Sheinin, and C.M. Lohse B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy Cancer Res 67 2007 7893
3. X. Zang, R.H. Thompson, and H.A. Al-Ahmadie B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome Proc Natl Acad Sci USA 104 2007 19458
4. A.S. Parker, M.G. Heckman, and Y. Sheinin Evaluation of B7-H3 expression as a biomarker of biochemical recurrence after salvage radiation therapy for recurrent prostate cancer Int J Radiat Oncol Biol Phys 79 2011 1343
5. A.I. Chapoval, J. Ni, and J.S. Lau B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production Nat Immunol 2 2001 269
6. W.K. Suh, S.X. Wang, and A.H. Jheon The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization Proc Natl Acad Sci USA 101 2004 12969
7. P. Steinberger, O. Majdic, and S.V. Derdak Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains J Immunol 172 2004 2352
8. G.B. Zhang, H. Zhou, and Y.J. Chen Characterization and application of two novel monoclonal antibodies against 2IgB7-H3: expression analysis of 2IgB7-H3 on dendritic cells and tumor cells Tissue Antigens 66 2005 83
9. + cytolytic T cells J Immunol 173 2004 5445
10. C.M. Lupu, C. Eisenbach, and M.A. Kuefner An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo J Gastrointest Surg 10 2006 635
11. R. Castriconi, A. Dondero, and R. Augugliaro Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis Proc Natl Acad Sci USA 101 2004 12640
12. W.K. Suh, B.U. Gajewska, and H. Okada The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses Nat Immunol 4 2003 899
13. D.V. Prasad, T. Nguyen, and Z. Li Murine B7-H3 is a negative regulator of T cells J Immunol 173 2004 2500
14. A. Fukushima, T. Sumi, and K. Fukuda B7-H3 regulates the development of experimental allergic conjunctivitis in mice Immunol Lett 113 2007 52
15. O. Merimsky, Y. Shoenfeld, and S. Chaitchik Antigens and antibodies in malignant melanoma Tumour Biol 15 1994 188
16. M. Streit, and M. Detmar Angiogenesis, lymphangiogenesis, and melanoma metastasis Oncogene 22 2003 3172
17. A.J. Miller, and M.C. Mihm Jr Melanoma N Engl J Med 355 2006 51
18. Y.W. Chen, C. Tekle, and O. Fodstad The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasion Curr Cancer Drug Targets 8 2008 404
19. G. Zhang, J. Hou, and J. Shi Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum Immunology 123 2008 538
20. J.C. Routh, R.A. Ashley, and T.J. Sebo B7-H1 expression in Wilms tumor: correlation with tumor biology and disease recurrence J Urol 179 2008 1954
21. C.Y. Tsai, T.S. Lee, and Y.R. Kou Glucosamine inhibits IL-1beta-mediated IL-8 production in prostate cancer cells by MAPK attenuation J Cell Biochem 108 2009 489
22. A.B. Fernandez-Martinez, A.M. Bajo, and M. Sanchez-Chapado Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells Prostate 69 2009 774
23. A. Yaqinuddin, S.A. Qureshi, and R. Qazi DNMT1 silencing affects locus specific DNA methylation and increases prostate cancer derived PC3 cell invasiveness J Urol 182 2009 756
24. Y. Sun, Y. Wang, and J. Zhao B7-H3 and B7-H4 expression in non-small-cell lung cancer Lung Cancer 53 2006 143
25. C.P. Wu, J.T. Jiang, and M. Tan Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis World J Gastroenterol 12 2006 457
26. G. Zhang, Y. Xu, and X. Lu Diagnosis value of serum B7-H3 expression in non-small cell lung cancer Lung Cancer 66 2009 245
27. G.X. Zhou, J. Ireland, and P. Rayman Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials Urology 75 2010 257
28. Q.S. Yang, J.L. Gu, and L.Q. Du ShRNA-mediated Ku80 gene silencing inhibits cell proliferation and sensitizes to gamma-radiation and mitomycin C-induced apoptosis in esophageal squamous cell carcinoma lines J Radiat Res (Tokyo) 49 2008 399
29. S.M. Wang, J. Zhu, and L.F. Pan Inhibitory effect of dimeric beta peptide on the recurrence and metastasis of hepatocellular carcinoma in vitro and in mice World J Gastroenterol 14 2008 3054
30. K.N. Syrigos, and A.J. Karayiannakis Adhesion molecules as targets for the treatment of neoplastic diseases Curr Pharmaceut Des 12 2006 2849